Breaking barriers in brain health
Mariel Schoen
How the Wyss Institute is advancing targeted therapies, early diagnosis, and collaborative models to confront neurodegenerative disease, mental illness, and brain cancer
For decades, some of the most urgent challenges in brain health have resisted progress across both academia and the pharmaceutical industry. At the Wyss Institute, we are tackling them head-on.
A central focus is overcoming one of the field’s biggest obstacles: delivering drugs effectively to the brain and central nervous...